Johan Bodegard - Dissemin

All papers authored by Johan Bodegard

This paper was not found in any repository, but could be made available legally by the author.

2023 Biykem Bozkurt

, Gianluigi Savarese

, Samuel Adamsson Eryd, Johan Bodegård

, John G. F. Cleland, Cindy Khordoc, Takuya Kishi, Marcus Thuresson, Orly Vardeny, Ruiqi Zhang, Lars H. Lund

Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization

Upload

Anna Norhammar

, Johan Bodegard

, Marc Vanderheyden, Navdeep Tangri, Avraham Karasik, Aldo Pietro Maggioni, Kari Anne Sveen, Tiago Taveira-Gomes, Manuel Botana, Lukas Hunziker, Marcus Thuresson, Amitava Banerjee

, Johan Sundström

, Andreas Bollmann

Prevalence, outcomes and costs of a contemporary, multinational population with heart failure

Upload

Gianluigi Savarese

, Takuya Kishi, Orly Vardeny, Samuel Adamsson Eryd, Johan Bodegård

, Lars H. Lund, Marcus Thuresson, Biykem Bozkurt

Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation

Upload

This paper is made freely available by the publisher.

2021 Ragnhild Sørum Falk

, Julian Eek Mariampillai

, Erik Edvard Prestgaard

, Trond Heir

, Johan Bodegård

, Trude Eid Robsahm

, Irene Grundvold

, Per Torger Skretteberg, Kristian Engeseth

, Jorgen Vildershoj Bjornholt

, Knut Stavem

, Knut Liestøl

, Leiv Sandvik, Erik Thaulow, Gunnar Erikssen

and 3 other authors

The Oslo Ischaemia Study: cohort profile

Download from doi.org

2019 Anna Norhammar

, Johan Bodegård

, Thomas Nyström

, Marcus Thuresson

, David Nathanson

, Jan W. Eriksson

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study

Download from api.wiley.com

Kåre I. Birkeland

, Johan Bodegard

, Anna Norhammar

, Josephina G. Kuiper, Elena Georgiado, Wendy L. Beekman‐Hendriks, Marcus Thuresson, Marc Pignot, Ron M. C. Herings, Adriaan Kooy

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

Upload

2018 Frederik Persson, Johan Bodegard

, Jorma T. Lahtela, Thomas Nyström, Marit E. Jørgensen, Majken Linneman Jensen, Hanne L. Gulseth, Marcus Thuresson, Fabian Hoti, David Nathanson, Anna Norhammar

, Kåre I. Birkeland

, Johan G. Eriksson, Jan W. Eriksson

Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study

Download from doi.org

Matthew A. Cavender, John P. Wilding, Thomas Nyström, Alex Z. Fu, Marcus Thuresson, Johan Bodegård

, Kamlesh Khunti

, Eric Wittbrodt, Reinhard W. Holl, David Nathanson

, Kåre I. Birkeland

, Anna Norhammar

, Marit Eika Jørgensen

, Niklas Hammar, Peter Fenici and 2 other authors

Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10

Download from diabetesjournals.org

2017 Almina Kalkan, Johan Bodegard

, Johan Sundström, Bodil Svennblad, Carl Johan Östgren, Peter Nilsson Nilsson, Gunnar Johansson, Mattias Ekman

Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes: A long-term follow-up in clinical practice

Download from doi.org

Thomas Nyström, Johan Bodegard

, David Nathanson, Marcus Thuresson, Anna Norhammar

, Jan W. Eriksson

Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes

Download from api.wiley.com

This paper is available in a repository.

Thomas Nyström, Johan Bodegard

, David Nathanson, Marcus Thuresson, Anna Norhammar

, Jan W. Eriksson

Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia

Download from doi.org

2016 Kristian Engeseth, Christian Hodnesdal, Irene Grundvold, Knut Liestøl, Knut Gjesdal, Sverre E. Kjeldsen, Jan E. Erikssen, Johan Bodegard

, Per Torger Skretteberg

Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle-Aged Men: a 28-Year Follow-Up Study.

Download from www.ahajournals.org

Anna Norhammar

, Johan Bodegård

, Thomas Nyström, Marcus Thuresson, Jan W. Eriksson, David Nathanson

Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013

Download from link.springer.com

Jan W. Eriksson, Johan Bodegard

, David Nathanson, Marcus Thuresson, Thomas Nyström, Anna Norhammar

Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality

Download from uu.diva-portal.org

Nina Johnston, Johan Bodegard

, Susanna Jerstrom, Johanna Åkesson, Johanna Akesson, Hilja Brorsson, Joakim Alfredsson, Per A. Albertsson, Jan-Erik Karlsson, Christoph Varenhorst

Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: A randomized study

Download from doi.org

2015 Lars Pål Hasvold, Marcus Thuresson, Johan Sundström, Niklas Hammar, Sverre Erik Kjeldsen, Gunnar Johansson, Ingar Morten K. Holme, Johan Bodegård

Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting

Download from www.ncbi.nlm.nih.gov

A. Lindh, F. Persson, P. Sobocki, J. Bodegard

, N. Lindarck

Nordic Longitudinal Data from Electronic Medical Records and Full Population National Registers: Unique Opportunities for New Insights in Benefit of Diabetes Patients

Download from doi.org

Ugne Sabale, Johan Bodegård

, Johan Sundström

, Carl Johan Östgren, Peter Nilsson, Gunnar Johansson, Bodil Svennblad, Martin Henriksson

Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting

Upload

Irene Grundvold, Johan Bodegard

, Peter M. Nilsson, Bodil Svennblad, Gunnar Johansson, Carl Johan Östgren, Johan Sundström

Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study

Download from link.springer.com

2014 Andreas Carlborg, Marcus Thuresson, Lena Ferntoft, Johan Bodegard

Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients

Download from journals.sagepub.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Johan Bodegard